Table 1

Demographics and outcomes of patients before and after the intervention

CharacteristicsPre-interventionPost-interventionP value
(n=100)(n=102)
Age (years) (mean (SD))62 (10.6)59 (10.5)0.038
Body mass index (mean (SD))32 (9.5)32 (9.2)0.8
Charlson comorbidity index (n (%))0.54
014 (14)16 (16)
119 (19)27 (26)
233 (33)30 (29)
 ≥3 34 (34)29 (28)
Previous abdominal surgery (n (%))56 (56)44 (43)0.092
Preoperative diagnosis (n (%))
Uterine cancer85 (85)72 (71)0.015
Ovarian cancer1 (1)10 (10)
Cervical cancer3 (3)3 (3)
Ovarian neoplasm (benign/borderline)11 (11)15 (15)
Other02 (2)*
MIS approach (n (%))
Laparoscopic63 (63)81 (79)0.015
Robotic37 (37)21 (21)
Nodal assessment (n (%))
None26 (26)29 (28)0.17
Sentinel node assessment43 (43)51 (50)
Full lymphadenectomy31 (31)22 (22)
Order of case (n (%))
First case of the day70 (70)61 (60)0.16
Second or third case of the day30 (30)41 (40)
Length of surgery (min) (mean (SD))211 (68.8)180 (59.7)<0.001
Conversion to laparotomy (n (%))8 (8)1 (1)0.018
Intraoperative transfusions (n (%))2 (2)2 (2)1
Intraoperative complications (n (%))1 (1)3 (3)0.62
Blood loss (mL) (median (range))0 (0–500)50 (0–800)0.33
Final FIGO stage (n (%))
Benign/borderline1 (1)19 (19)<0.001
180 (80)64 (63)
215 (15)11 (11)
33 (3)7 (7)
41 (1)1 (1)
Uterine weight (g) (median (range))117 (45–298)120 (11–641)0.34
  • *Other refers to one case of myometrium lipoleiomyoma and another case of cervical spindle cell proliferation not otherwise classified

  • SD, standard deviation; MIS, minimally invasive surgery; FIGO, International Federation of Gynecology and Obstetrics.